CoChat

Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma

Open access
Matsumura, N, Ohtsuka, M, Kikuchi, N, Yamamoto, T · 2016 · Acta Dermato Venereologica
Cited by 99

The DOI matches its Crossref record.

Abstract

© 2016 The Authors. doi: 10.2340/00015555-2212 Journal Compilation © 2016 Acta Dermato-Venereologica. ISSN 0001-5555 Programmed cell death (PD)-1 is an immune checkpoint receptor expressed on antigen-stimulated T cells. Several types of anti-PD-1 antibodies have demonstrated a remarkable benefit for metastatic melanoma, with a low incidence of severe adverse events. A fully human antiPD-1 antibody, nivolumab, has been approved in Japan for patients with unresectable melanoma. We report here a case of metastatic melanoma with lung metastasis in which psoriasis was exacerbated along with the development of interstitial pneumonia during nivolumab therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2340/00015555-2212

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 99

Metadata

Authors
Matsumura, N., Ohtsuka, M., Kikuchi, N., & Yamamoto, T.
Venue
Acta Dermato Venereologica
Published
2016
Volume
96
Issue
2
Pages
259-260
ISSN
0001-5555 (ISSN-L)
OpenAlex
W2324653442
Cited by
99
References
0
FWCI
5.85
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma. https://app.cochat.ai/papers/10.2340/00015555-2212
The paper
Matsumura, N., Ohtsuka, M., Kikuchi, N., & Yamamoto, T. (2016). Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-2212

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.